A Study to Assess the Safety of Brexanolone in the Treatment of Adolescent Female Participants With Postpartum Depression (PPD)
NCT03665038
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
28
Enrollment
INDUSTRY
Sponsor class
Conditions
Post Partum Depression
Interventions
DRUG:
Brexanolone
Sponsor
Supernus Pharmaceuticals, Inc.